FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

G Protein topics
Antibodies
Nucleic Acid
G Proteins
Nucleic Acids
Amino Acid
Polypeptide
Protein A Affinity Chromatography
Chromatography
Chromatograph
Liver Metastasis
Membrane Protein
Colorectal Carcinoma
Rectal Carcinoma
Prophylactic
Glycoprotein

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

G Protein patents



      
           
This page is updated frequently with new G Protein-related patent applications. Subscribe to the G Protein RSS feed to automatically get the update: related G RSS feeds. RSS updates for this page: G Protein RSS RSS


Date/App# patent app List of recent G Protein-related patents
02/26/15
20150059009
 Methods for making fully human bispecific antibodies using a common light chain patent thumbnailnew patent Methods for making fully human bispecific antibodies using a common light chain
A genetically modified mouse is provided, wherein the mouse expresses an immunoglobulin light chain repertoire characterized by a limited number of light chain variable domains. Mice are provided that express just one or a few immunoglobulin light chain variable domains from a limited repertoire in their germline.
Regeneron Pharmaceuticals, Inc.
02/26/15
20150057243
 Compositions and methods for the inhibition of methyltransferases patent thumbnailnew patent Compositions and methods for the inhibition of methyltransferases
Methods and compositions disclosed herein relate to detecting, analyzing, isolating and inhibiting methyltransferases, methyltransferase substrates, s-adenosyl-methionine-binding proteins and rna, including for the treatment of disease.. .
Northern University
02/26/15
20150056680
 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses patent thumbnailnew patent Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
The present invention concerns methods and compositions for stably tethered structures of defined compositions, which may have multiple functionalities and/or binding specificities. Particular embodiments concern homodimers comprising monomers that contain a dimerization and docking domain attached to a precursor.
Ibc Pharmaceuticals, Inc.
02/26/15
20150056675
 Hydrocarbon synthase gene and use thereof patent thumbnailnew patent Hydrocarbon synthase gene and use thereof
A hydrocarbon synthase gene encoding protein having excellent capacity to synthesize a hydrocarbon such as alkane and novel functions is provided. The gene encodes a protein comprising an amino acid sequence comprising a motif sequence shown in seq id no: 1 and having activity of synthesizing a hydrocarbon with a carbon number one less than that of an aldehyde compound from the aldehyde compound..
Toyota Jidosha Kabushiki Kaisha
02/26/15
20150056634
 Methods for preparing dry formulations of glucose binding protein patent thumbnailnew patent Methods for preparing dry formulations of glucose binding protein
Methods and compositions for preparing dry formulations of glucose binding proteins (gbps) are disclosed. The gbps may be stored as a dry formulation without significant loss of activity.
Becton, Dickinson And Company
02/26/15
20150056629
 Compositions, systems, and methods for detecting a dna sequence patent thumbnailnew patent Compositions, systems, and methods for detecting a dna sequence
Provided are compositions, systems, and methods that employ one or more fusion protein pairs, wherein each fusion protein within a fusion protein pair comprises a sequence-specific nucleic acid binding protein, such as sequence-specific cas9 protein (e.g., a crispr), a sequence specific transcription activator-like enhancer (“tale”) protein, a sequence specific homing endonuclease (“he”; a/k/a meganuclease), a three prime exonuclease (“trex”), and/or a sequence specific zinc finger (“zf”) protein, which sequence-specific nucleic acid binding protein is operably linked to one half of a split-reporter molecule, such as a split-fluorescent reporter molecule, a split-luminescent reporter molecule, a förster resonance energy transfer (fret) reporter molecule, or a bioluminescence resonance energy transfer (bret) reporter molecule.. .
02/26/15
20150056360
 Creamer composition comprising protein, low molecular weight emulsifiers and hydroxypropyl starch patent thumbnailnew patent Creamer composition comprising protein, low molecular weight emulsifiers and hydroxypropyl starch
The present invention relates to a creamer composition, e.g. For use for addition into a coffee beverage, having good physical stability and mouthfeel even at low fat levels or as a fat free creamer composition.
Nestec S.a.
02/26/15
20150056211
 Heparin-binding epidermal growth factor-like growth factor binding proteins patent thumbnailnew patent Heparin-binding epidermal growth factor-like growth factor binding proteins
Provided herein are antigen binding proteins, e.g., human and/or monoclonal antibodies that have affinity for heparin-binding epidermal growth factor-like growth factor (hb-egf) and neutralize the biological functions of this growth factor.. .
Amgen, Inc.
02/26/15
20150056202
 Anti-tnf/il-17 dual variable domain immunoglobulin and uses thereof patent thumbnailnew patent Anti-tnf/il-17 dual variable domain immunoglobulin and uses thereof
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention and/or treatment of acute and chronic inflammatory and other diseases.. .
Abbvie, Inc.
02/19/15
20150051283
 Composition and  inhibition of pkng from mycobacterium tuberculosis patent thumbnailComposition and inhibition of pkng from mycobacterium tuberculosis
Pkng from mycobacterium tuberculosis is a ser/thr protein kinase that regulates key metabolic processes within the bacterial cell as well as signaling pathways from the infected host cell. This multi-domain protein has a conserved canonical kinase domain with n- and c-terminal flanking regions of unclear functional roles.
Complexa, Inc.
02/19/15
20150051093

Reagents and methods for detecting protein lysine 3-hydroxybutyrylation


The invention provides an isolated peptide comprising a lysine 3-hydroxybutyrylation site, a lysine 3-hydroxybutyrylation specific affinity reagent that specifically binds to the peptide, and a method for detecting protein lysine 3-hydroxybutyrylation in a sample using the reagent.. .
Ptm Biolabs, Inc.
02/19/15
20150050738

Compositions and methods for modulating rna


Aspects of the invention relate to methods for increasing gene expression in a targeted manner. In some embodiments, methods and compositions are provided that are useful for posttranscriptionally altering protein and/or rna levels in a targeted manner.
Rana Therapeutics, Inc.
02/19/15
20150050715

Stably tethered structures of defined compositions with multiple functions or binding specificities


The present invention concerns methods and compositions for stably tethered structures of defined compositions with multiple functionalities and/or binding specificities. Particular embodiments concern stably tethered structures comprising a homodimer of a first monomer, comprising a dimerization and docking domain attached to a first precursor, and a second monomer comprising an anchoring domain attached to a second precursor.
Ibc Pharmaceuticals, Inc.
02/19/15
20150050671

Method for species-independent measurement of complement activation in animals


A method for species-independent measurement of complement (c) activation in animals. The method comprises taking samples in the range of 3-100 microliter of anticoagulated blood, plasma or serum of an animal (specimen), mixing the specimen with a specificity converting protein matrix (scm), mixing to the specimen/scm mixture an activator of the c system (act), incubating the specimen/scm/act mixture at a temperature between 36° c.
Tecomedical Ag
02/19/15
20150050351

Stereoisomer peptides, their polymer conjugates, their encapsulation into nanoparticles, and uses thereof for the treatment of diseases caused by abnormal angiogenesis.


This invention discloses the creation of a novel single ligand-targeted multi-stereoisomer peptide-polymer conjugate compounds comprising a group of different synthetic and chemically modified stereoisomer peptides that have been conjugated to a biocompatible polymer carrying a peptide ligand for targeted delivery and/or encapsulated in ligand targeted polymer nanoparticles. The unique physicochemical properties of the stereoisomer peptides provide therapeutic compounds with ideal biopharmaceutical properties.
02/19/15
20150050279

B-cell receptor complex binding proteins containing t-cell epitopes


The present invention relates to a polypeptide comprising a) a binding peptide binding to at least one protein selected from the group consisting of cd22, cd19, cd20, and cd21, and b) an immunogenic peptide comprising at least one t-cell epitope for use in vaccination of a subject against b-cell hyperproliferation or for use in the modulation of the immune response in a subject. The present invention further relates to a polynucleotide and a vector encoding said polypeptide and a host cell comprising the same.
Deutsches Krebsforschungszentrum
02/19/15
20150050238

Treatment of osteoarthritis and pain


The present invention relates to the treatment of osteoarthritis and pain using il-1α and il-1β binding proteins, including anti-il-1α and anti-il-1β antibodies and engineered multivalent and multispecific il-1α and il-1β binding proteins.. .
Abbvie Inc.
02/12/15
20150045540

Multispecific stacked variable domain binding proteins


The present invention concerns multi-specific stacked variable domain binding proteins.. .
Sea Lane Biotechnologies, Llc
02/12/15
20150045414

Trans-acting rna switches


Disclosed are rna constructs which function to activate or inactivate a biological process, e.g., may be designed for attachment to a polypeptide coding region. Such rna constructs modulate translation of a polypeptide from the coding region in response to the presence of a target polynucleotide in an expression environment.
The Research Foundation Of The University Of New York
02/12/15
20150045358

Pharmaceutical composition for treating disorders associated with insulin resistance


A pharmaceutical composition for treating disorders associated with insulin resistance is disclosed, and the composition comprises at least one inhibitor which is an effective agent to suppress endothelin-1-stimulated resistin gene expression through decreasing the endothelin-1-stimulated phosphorylation of proteins downstream of endothelin type a receptor, wherein the downstream signaling molecules comprise erk1/2, jnks, akt, and stat3 proteins, and wherein the inhibitor is selected from at least one antagonist of the endothelin type a receptor or downstream signaling proteins.. .
National Central University
02/12/15
20150045294

Energy-rich liquid nutritional composition having improved organoleptic properties


The object of the present invention is to provide a liquid enteral composition for providing nutrition, either as a supplement, or as a complete nutrition, comprising a high protein content, in particular micellar casein as major protein source, in a small volume of liquid, in particular 6 to 20 g protein per 100 ml of the liquid composition, the composition further comprising lactic acid and having a ph in the range of 6 to 8. It is also an object of the invention to provide an improved manufacturing process for such liquid enteral compositions..
N.v. Nutricia
02/12/15
20150044768

Methods and compositions for production of recombinant protein in hbx-expressing mammalian cells


The method of the invention provides for producing a heterologous protein in mammalian host cells having nucleic acid encoding hepatitis b x protein and the heterologous protein, by growing mammalian host cells selected from the group consistng of hkb11, cho, bhk21, c2c12, and hek293 cells, by growing mammalian host cells in non-adherent suspension culture, or by growing mammalian host cells which contain nucleic acid providing exogenous x-box binding protein, xbp1s. The conditions should be such that hbx, exogenous xbp1s if present, and the heterologous protein are expressed by the mammalian cells.
Bayer Healthcare Llc
02/12/15
20150044712

Method and kit for analyzing protein-protein interaction using nanocluster formation


For efficient analysis of a protein-protein interaction, the present disclosure provides a kit for analyzing a protein-protein interaction, the kit including: a 1st expression vector including a 1st polynucleotide and a multi-cloning site, wherein, the 1st polynucleotide is operably linked to a promoter and encodes a 1st fusion protein having a 1st fluorescence protein and a 1st self-assembly protein, and the multi-cloning site is a site where a polynucleotide encoding a bait protein may be operably linked to the polynucleotide encoding the 1st fusion protein; and a 2nd expression vector including a 2nd polynucleotide and a multi-cloning site, wherein, the 2nd polynucleotide is operably linked to a promoter and encodes a 2nd fusion protein having a 2nd fluorescence protein and a 2nd self-assembly protein, and the multi-cloning site is a site where a polynucleotide encoding a prey protein may be operably linked to the polynucleotide encoding the 2nd fusion protein.. .
Korea Advanced Institute Of Science And Technology
02/12/15
20150044705

Protein detection using modified cyclodextrins


A method is provided for detecting a protein using a cyclodextrin covalently linked to at least one label. The cyclodextrin can associate with the protein by sequestering an aromatic amino acid side-chain of the protein in its hydrophobic cavity.
Bio-rad Laboratories, Inc.
02/12/15
20150044236

Carrier immunoglobulins


Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it.
Amgen Inc.
02/12/15
20150044235

Carrier immunoglobulins


Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it.
Amgen Inc.
02/12/15
20150044214

Bispecific, tetravalent antigen binding proteins


The present invention relates to bispecific, tetravalent antigen binding proteins, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.. .
Hoffmann-la Roche, Inc.
02/12/15
20150044213

Protein sustained-release injectable formulation


The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexpla).
Esbatech - A Novartis Company Llc
02/12/15
20150044162

Anticancer fusion protein


A fusion protein comprising domain (a) which is a functional fragment of htrail protein sequence, which fragment begins with an amino acid at a position not lower than htrail95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid htrail281; and domain (b) which is a sequence of an effector peptide inhibiting protein synthesis, wherein the sequence of domain (b) is attached at the c-terminus or n-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases..
Adamed Sp. Z.o.o.
02/05/15
20150039240

Protein identification method and system


When a terminal sequence to be investigated is specified (s1), a corresponding protein is extracted from a database containing known proteins linked with terminal sequences (s2). If one protein cannot be uniquely identified (“no” in s5), amino-acid residues to be bonded to the target terminal sequences are selected, and new terminal sequences with the selected amino-acid residues respectively added are created for further investigation (s7).
Shimadzu Corporation
02/05/15
20150038459

Protein containing food stuffs


Nutritious protein-containing foodstuffs can be prepared in the form of gels, including protein gel and fruit purees that contain all essential amino acids. A protein gel for use as a foodstuff is prepared by heating an aqueous protein solution to between 160 and 185 degrees fahrenheit at an acidic ph between 2.85 and 3.5, the protein solution having a viscosity greater than 100 centipoise and containing a protein at a concentration of 10-20% w/w, the protein being at least one of a whey protein isolate and a liquid soy protein isolate, the protein gel having a viscosity of between 10,000 and 1,000,000 centipoise..
Jump Brands, Llc
02/05/15
20150038423

Delivery of therapeutic agents by a collagen binding protein


Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. Methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a pth/pthrp receptor agonist are provided.
Montefiore Medical Center
02/05/15
20150037867

Purification method


The invention provides methods for purifying protein products.. .
Castech Laboratories, Llc
02/05/15
20150037421

Arrdc1-mediated microvesicles (armms) and uses thereof


The invention provide isolated arrestin domain-containing protein 1 (arrdc1)-mediated micro vesicles (armms). Methods for generating and for isolating armms are also provided herein.
The Board Of Trustees Of The Leland Stanford Junioruniversity
02/05/15
20150037344

Therapeutic agent


The present invention relates to agents which modulate the effect of a ramp (receptor activity modifying protein) protein on a calcitonin receptor like receptor (crlr). Also included in the present invention are methods and uses of such agents and assays for identifying such agents.
Medella Therapeutics
02/05/15
20150037340

Novel antigen binding protein and its use as addressing product for the treatment of cancer


The present invention relates to an antigen binding protein, in particular a monoclonal antibody, capable of binding specifically to the protein axl as well as the amino and nucleic acid sequences coding for said protein. From one aspect, the invention relates to an antigen binding protein, or antigen binding fragments, capable of binding specifically to axl and, by inducing internalization of axl, being internalized into the cell.
Pierre Fabre Medicament
02/05/15
20150037339

Anti-activin a antibodies and uses thereof


The present invention provides antibodies that bind to activin a and methods of using the same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to activin a with high affinity.
Regeneron Pharmaceuticals, Inc.
02/05/15
20150037336

Combination of hb-egf binding protein and egfr inhibitor


The present application relates to the combined use of an antigen-binding protein that binds hb-egf and an egfr tyrosine kinase inhibitor in medical treatment.. .
U3 Pharma Gmbh
02/05/15
20150037335

Therapeutic use of p75ntr neurotrophin binding protein


The present invention relates to a p75ntr neurotrophin binding protein, p75ntr(nbp), for use in the treatment of pain and/or a symptom of pain.. .
Levicept Ltd
02/05/15
20150037312

Binding proteins to the constant region of immunoglobulin g


The present invention provides polypeptides that bind to immunoglobulin g and methods for their use.. .
University Of Washington Through Its Center For Commercialization
02/05/15
20150037294

Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1


The present invention provides methods for promoting wound healing and treating muscle atrophy in a mammal in need. The method comprises administering to the mammal a nell1 protein or a nell1 nucleic acid molecule..
Ut-battelle, Llc
02/05/15
20150037248

Il-1beta neutralizing human monoclonal antibodies


The present invention is directed to antigen binding proteins and in particular to il-1β antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production..
Agency For Science, Technology And Research
01/29/15
20150031870

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)


Antigen binding proteins that interact with proprotein convertase subtilisin kexin type 9 (pcsk9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to pcsk9 are described.
Amgen Inc.
01/29/15
20150031676

Substituted benzothienyl-pyrrolotriazines and uses thereof


This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.. .
Bayer Intellectual Property Gmbh
01/29/15
20150031633

Bifunctional peptide


The bifunctional peptide is capable of activating collagen synthesis and inhibiting the production of matrix metallo-proteinases. The peptide has a sequence including three peptide parts a, b and c.
Centre National De La Recherche Scientifique
01/29/15
20150031581

Methods and kits for determining protein-bound biomarkers


(a) automated prepurification of the sample using an effective amount of an acid protease under conditions that allow for digestion of one or more binding proteins; (b) applying said protease-digested sample onto an on-line spe column to capture at least part of said biomarker, followed by sequential washing of the solid phase; (c) eluting a fraction comprising said biomarker directly onto a liquid chromatography (lc) column comprising an apolar stationary phase and subjecting it to lc-ms or lc-ms-ms measurements to determine the amount of at least one biomarker; and (d) quantitating the biomarker(s). Also provided are kits for use in such method, for instance in the determination of vitamin d derivatives, testosterone and/or or melatonin..
01/29/15
20150030593

Compositions of penetration-enhanced targeting proteins and methods of use


The disclosure relates to penetration-enhanced targeted proteins and their uses for therapeutics delivery.. .
Permeon Biologics, Inc.
01/29/15
20150030580

Pegylated fibrinogen precursor molecule


The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides pegylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration..
Regentis Biomaterials Ltd.
01/22/15
20150025128

Method for producing protein


The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of ero1 and xbp1 relative to the expression levels of ero1 and xbp1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell..
Ucb Pharma S.a.
01/22/15
20150025013

Compositions and methods of use for (pro)renin receptor


Disclosed are methods of treating kidney disease, infectious or inflammatory diseases, acute kidney injury and hypertension by administering a (pro)renin receptor (prr) antagonist. In some instances the prr antagonist is a polypeptide.
University Of Utah


Popular terms: [SEARCH]

G Protein topics: Antibodies, Nucleic Acid, G Proteins, Nucleic Acids, Amino Acid, Polypeptide, Protein A Affinity Chromatography, Chromatography, Chromatograph, Liver Metastasis, Membrane Protein, Colorectal Carcinoma, Rectal Carcinoma, Prophylactic, Glycoprotein

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to G Protein for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for G Protein with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         









1.0044

3213

2 - 1 - 71